C

China National Medicines Corp Ltd
SSE:600511

Watchlist Manager
China National Medicines Corp Ltd
SSE:600511
Watchlist
Price: 34.38 CNY -0.12% Market Closed
Market Cap: 25.9B CNY
Have any thoughts about
China National Medicines Corp Ltd?
Write Note

China National Medicines Corp Ltd
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

China National Medicines Corp Ltd
Long-Term Investments Peer Comparison

Comparables:
1099
601607
600998
000963
Q
301015

Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
C
China National Medicines Corp Ltd
SSE:600511
Long-Term Investments
ÂĄ1.9B
CAGR 3-Years
19%
CAGR 5-Years
19%
CAGR 10-Years
19%
Sinopharm Group Co Ltd
HKEX:1099
Long-Term Investments
ÂĄ10.6B
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
24%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Long-Term Investments
ÂĄ10.9B
CAGR 3-Years
1%
CAGR 5-Years
14%
CAGR 10-Years
13%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Long-Term Investments
ÂĄ5.1B
CAGR 3-Years
-4%
CAGR 5-Years
24%
CAGR 10-Years
30%
Huadong Medicine Co Ltd
SZSE:000963
Long-Term Investments
ÂĄ2.2B
CAGR 3-Years
23%
CAGR 5-Years
47%
CAGR 10-Years
32%
Q
Qingdao Baheal Medical Inc
SZSE:301015
Long-Term Investments
ÂĄ264.3m
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
N/A

See Also

What is China National Medicines Corp Ltd's Long-Term Investments?
Long-Term Investments
1.9B CNY

Based on the financial report for Jun 30, 2024, China National Medicines Corp Ltd's Long-Term Investments amounts to 1.9B CNY.

What is China National Medicines Corp Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
19%

Over the last year, the Long-Term Investments growth was 15%. The average annual Long-Term Investments growth rates for China National Medicines Corp Ltd have been 19% over the past three years , 19% over the past five years , and 19% over the past ten years .

Back to Top